N-acetylcysteine does not prevent contrast-induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: a randomized clinical trial

BACKGROUND: Patients with diabetes mellitus (DM) and chronic kidney disease (CKD) constitute to be a high-risk population for the development of contrast-induced nephropathy (CIN), in which the incidence of CIN is estimated to be as high as 50%. We performed this trial to assess the efficacy of N-ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Amini, Manouchehr, Salarifar, Mojtaba, Amirbaigloo, Alireza, Masoudkabir, Farzad, Esfahani, Fatemeh
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714294/
https://www.ncbi.nlm.nih.gov/pubmed/19563648
http://dx.doi.org/10.1186/1745-6215-10-45

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714294/
https://www.ncbi.nlm.nih.gov/pubmed/19563648
http://dx.doi.org/10.1186/1745-6215-10-45

Ejemplares similares